Regencell Bioscience Holdings Ltd (RGC) Wheel Strategy

Running a RGC wheel strategy lets you generate consistent premium income on Regencell Bioscience Holdings Ltd while setting your own entry and exit prices on the underlying. Regencell Bioscience Holdings Ltd's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own RGC, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best RGC wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on RGC, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable RGC wheel from a losing one.

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the RGC wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your RGC wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.